Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients A randomized crossover clinical trial

被引:209
作者
Azadbakht, Leila [1 ,2 ]
Fard, Nafiseh Rashidi Pour [3 ]
Karimi, Majid [3 ]
Baghaei, Mohammad Hassan [3 ]
Surkan, Pamela J. [4 ]
Rahimi, Majid [3 ]
Esmaillzadeh, Ahmad [1 ,2 ]
Willett, Walter C. [5 ,6 ]
机构
[1] Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Sch Publ Hlth, Dept Nutr, Esfahan, Iran
[3] Shaheed Motahari Hosp, Fooladshahr, Isfahan, Iran
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[5] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
BLOOD-PRESSURE; ASSOCIATION; PROTEIN; FAT;
D O I
10.2337/dc10-0676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) eating pattern on cardiometabolic risks in type 2 diabetic patients. RESEARCH DESIGN AND METHODS- A randomized crossover clinical trial was undertaken in 31 type 2 diabetic patients. For 8 weeks, participants were randomly assigned to a control diet or the DASH eating pattern. RESULTS- After following the DASH eating pattern, body weight (P = 0.007) and waist circumference (P = 0.002) reduced significantly. Fasting blood glucose levels and A1C decreased after adoption of the DASH diet (-29.4 +/- 6.3 mg/dl; P = 0.04 and -1.7 +/- 0.1%; P = 0.04, respectively). After the DASH diet, the mean change for HDL cholesterol levels was higher (4.3 +/- 0.9 mg/dl; P = 0.001) and LDL cholesterol was reduced (-17.2 +/- 3.5 mg/dl; P = 0.02). Additionally, DASH had beneficial effects on systolic (-13.6 +/- 3.5 vs. -3.1 +/- 2.7 mmHg; P = 0.02) and diastolic blood pressure (-9.5 +/- 2.6 vs. -0.7 +/- 3.3 mmHg; P = 0.04). CONCLUSIONS- Among diabetic patients, the DASH diet had beneficial effects on cardiometabolic risks.
引用
收藏
页码:55 / 57
页数:3
相关论文
共 15 条
[1]  
Anderson JW, 2006, MODERN NUTR HLTH DIS, P1051
[2]   Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids - Results of the OmniHeart randomized trial [J].
Appel, LJ ;
Sacks, FM ;
Carey, VJ ;
Obarzanek, E ;
Swain, JF ;
Miller, ER ;
Conlin, PR ;
Erlinger, TP ;
Rosner, BA ;
Laranjo, NM ;
Charleston, J ;
McCarron, P ;
Bishop, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2455-2464
[3]   Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome [J].
Azadbakht, L ;
Mirmiran, P ;
Esmaillzadeh, A ;
Azizi, T ;
Azizi, F .
DIABETES CARE, 2005, 28 (12) :2823-2831
[4]   Soy protein intake, carchorenal indices, and C-reactive protein in type 2 diabetes with nephropathy - A longitudinal randomized clinical trial [J].
Azadbakht, Leila ;
Atabak, Shahnaz ;
Esmaillzadeh, Ahmad .
DIABETES CARE, 2008, 31 (04) :648-654
[5]   Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association [J].
Buse, John B. ;
Ginsberg, Henry N. ;
Bakris, George L. ;
Clark, Nathaniel G. ;
Costa, Fernando ;
Eckel, Robert ;
Fonseca, Vivian ;
Gerstein, Hertzel C. ;
Grundy, Scott ;
Nesto, Richard W. ;
Pignone, Michael P. ;
Plutzky, Jorge ;
Porte, Daniel ;
Redberg, Rita ;
Stitzel, Kimberly F. ;
Stone, Neil J. .
CIRCULATION, 2007, 115 (01) :114-126
[6]  
Fleiss JL, 1986, DESIGN ANAL CLIN EXP, P263
[7]   Energy density and weight change in a long-term weight-loss trial [J].
Flood, Andrew ;
Mitchell, Nathan ;
Jaeb, Melanie ;
Finch, Emily A. ;
Laqua, Patricia S. ;
Welsh, Ericka M. ;
Hotop, Annie ;
Langer, Shelby L. ;
Levy, Rona L. ;
Jeffery, Robert W. .
INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY, 2009, 6 :57
[8]   Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women [J].
Forman, John P. ;
Stampfer, Meir J. ;
Curhan, Gary C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04) :401-411
[9]  
Harris TJ, 2000, NUTR METAB CARDIOVAS, V10, P305
[10]  
Kalofoutis Christos, 2007, Exp Clin Cardiol, V12, P17